Upprop: Vi kräver en debatt om EU:s gröna certifikat / Sveriges vaccinpass

Upprop: Vi kräver en debatt om EU:s gröna certifikat / Sveriges vaccinpass

Upprop: vi kräver en debatt om EU:s gröna certifikat / Sveriges vaccinpass

Genom att gå med uppropet skickas nedanstående öppna brev från Children’s Health Defense Europe till 615 parlamentariker i den Europeiska Unionen.

Brevets hem:

  • https://childrenshealthdefense.eu/take-action/take-action-green-pass-requires-debate-not-emergency-adoption/

 

March 22, 2021

Green Pass: Letter of Children’s Health Defense to the European Parliament. TAKE ACTION

Dear Member of the European Parliament,

Re: Green Pass Requires Debate, Not Emergency Adoption, COM 2021 130

We write to oppose the Parliament’s adoption of the “Green Pass” (Digital Green Certificate, introduced March 17, 2021 with proposal #COM 2021 130) without thorough, vigorous debate. While the intent of the Green Pass is to facilitate travel during the COVID-19 pandemic, we fear it will do the exact opposite: it will stifle travel and human interaction.

We are extremely concerned about the proposed regulation will affect all travel in the Schengen Zone, for European citizens and others alike, requiring individuals to prove receipt of an experimental vaccine or submission to experimental testing.

The proposal’s premise is that it will prevent transmission of SARS-Cov-2 but it is on shaky scientific and legal ground and requires in-depth debate for the reasons listed below.

1. There is No Proof that Vaccination Blocks Transmission of SARS-CoV-2.

The European Medicines Agency (EMA) has repeatedly stated that there is no data proving that COVID-19 vaccines block transmission of the coronavirus. For this reason, vaccinated individuals must continue to maintain social distancing and mask wearing.

While the EMA hopes vaccines will reduce COVID, the reverse may occur; mass vaccination may increase disease spread. This was the case with the Dengvaxia vaccine in the Philippines, as the World Health Organization (WHO) Vaccine Safety Summit detailed in 2019. Independent scientists assessing results in Israel and the United Kingdom question the success of mass vaccination. As coronaviruses are constantly mutating, the effectiveness of these novel vaccines against new variants is doubtful.

2. PCR Tests Are Unreliable Public Health Measures.

While PCR tests may be able to diagnose a sick person in a short time window, they have almost no relevance for those who show no symptoms of illness. Positive PCR tests do not confirm illness or contagiousness and many result in ‘false positive cases’.

A recent review in the medical journal The Lancet estimated that isolation of false positive cases is “a net loss to the health, social and economic wellbeing of communities” and concluded that “PCR testing is therefore not the appropriate gold standard for evaluating a SARS-CoV-2 public health test.

In January 2021, the WHO released new guidance on PCR tests, also warning of the danger of false positive results: “as disease prevalence decreases, the risk of false positive increases.”

Member states should stop testing healthy people and use those resources for treatment.

3. The Green Pass is legally disproportionate.

The proposed regulations infringe fundamental human rights, including rights to travel, assembly, privacy, conscience and free and informed consent. Recent scientific studies cast serious doubt on the effectiveness of draconian measures to limit disease spread, including travel restrictions and lockdown measures.

Implementing the Green Pass will require massive resources without a well-founded expectation of success. Investment in hospitals and protections for those at risk would be more effective and economical. At the very least, a cost–benefit analysis and debate are absolutely necessary.

4. The European Parliament Must Apply the Precautionary Principle.

COVID-19 vaccines have received only conditional approval; clinical trials will not be complete for months or years. Demanding that European Union citizens and visitors be subject to experimental medical products to exercise fundamental rights violates the precautionary principle enshrined in Article 191 of the Treaty of Functioning of the European Union.

How these vaccines will affect people in coming months or years is unknown.  The risk of Antibody Dependent Enhancement (ADE) is real, i.e. that vaccinated individuals exposed to new viral strains may be at increased risk compared to those who have not been vaccinated. This potentially lethal risk is well-known to vaccine experts and is one of the main reasons why vaccine manufacturers refuse to accept liability for future injuries and deaths.

Several COVID-19 vaccines are based on a novel gene technology never used in healthy individuals before. Manufacturers sidelined the risks in modifying the human genome and triggering autoimmune diseases in the headlong rush to release the vaccines. On July 15, 2020, the European Parliament voted to waive the risk assessment for these vaccines under the Genetically Modified Organism (GMO) Regulation. Prominent scientists and doctors recently addressed these concerns in an open letter to the EMA. Further study on the impact of these gene therapies is required before making them compulsory.

5. Vaccine Manufacturers Fail to Warrant Effectiveness or Safety.

Esteemed Belgium lawyers recently concluded that the European Commission granted invalid liability and warranty exemptions to COVID-19 vaccine manufacturers. Given the lack of evidence of safety or effectiveness, manufacturers unsurprisingly refuse to guarantee either. Member States, and ultimately the electorate, will bear the burden of compensating and caring for victims of vaccine injury.

6. Inadequate Guarantee of Data Privacy.

Although the proposed regulation states that Member States will protect medical data, there is little to guarantee this protection. These medical data may be used to discriminate against individuals in violation of fundamental rights and freedoms.

7. Risk of Type Replacement and Viral Mutation.

Mass vaccination with imperfect vaccines – and none of the available vaccines is perfect – may lead to type replacement and viral mutation. It may well be vaccinated individuals, not unvaccinated ones, that pose the greatest risk of new, more virulent types of coronavirus infection. The classic example of this kind of type replacement occurred with widespread use of the pertussis vaccine, which led to new viral mutations that the existing vaccine did not block. In other words, it is unclear that mass vaccination will lead to an end to the coronavirus crisis.

8. Risk that Green Passes Become Permanent Without Due Consideration.

While the Parliament considers the Green Pass regulation as a temporary measure, it is unlikely to be so. Such restrictions usually become permanent, making the need for robust debate the more important. Could more vaccines be required under the Green Pass at a later date? Why should the Director-General of the World Health Organization have the power to make decisions about them? The long-term implications of the Green Pass require deliberation.

9. The European Parliament Must Uphold Democratic Values.

Too often since the beginning of the coronavirus pandemic, numbers have ruled instead of the rule of law. Small coteries of experts interpreting numbers have set policy instead of democratic legislatures and civil society. Numbers and studies are too often tailored to serve those who produce them. Europe cannot thrive if it relies on mathematical models to the exclusion of human models. The Parliament is entrusted to uphold democratic values.

***

Please take these points above into consideration and require open debate and analysis before you take further action on the Green Pass.

The citizens of Europe and the world are watching you — our liberty and security are in your hands. Do not let us down! Do not put the future of the European Union in jeopardy by desecrating one of its most fundamental principles: free movement within the Schengen Area.

Yours sincerely,

Robert F. Kennedy, Jr.
Chair, Children’s Health Defense

Senta Depuydt
President, Children’s Health Defense Europe

 

Green pass: We demand a freeze on the decision and an open debate

Dear MEP

We demand an open debate and immediate freeze on the so-called green pass.

Please find below the rationale, courtesy Children’s Health Defense Europe.

----------------------------------

Direct link to pdf:

https://childrenshealthdefense.eu/wp-content/uploads/CHD-Letter-to-Eur-Parliament_RFK-SD.pdf

Full text below:

----------------------------------

Dear Member of the European Parliament,

Re: Green Pass Requires Debate, Not Emergency Adoption, COM 2021 130

We write to oppose the Parliament’s adoption of the “Green Pass” (Digital Green Certificate, introduced March 17, 2021 with proposal #COM 2021 130) without thorough, vigorous debate. While the intent of the Green Pass is to facilitate travel during the COVID-19 pandemic, we fear it will do the exact opposite: it will stifle travel and human interaction.

We are extremely concerned about the proposed regulation will affect all travel in the Schengen Zone, for European citizens and others alike, requiring individuals to prove receipt of an experimental vaccine or submission to experimental testing.

The proposal’s premise is that it will prevent transmission of SARS-Cov-2 but it is on shaky scientific and legal ground and requires in-depth debate for the reasons listed below.

1. There is No Proof that Vaccination Blocks Transmission of SARS-CoV-2.

The European Medicines Agency (EMA) has repeatedly stated that there is no data proving that COVID-19 vaccines block transmission of the coronavirus. For this reason, vaccinated individuals must continue to maintain social distancing and mask wearing.

While the EMA hopes vaccines will reduce COVID, the reverse may occur; mass vaccination may increase disease spread. This was the case with the Dengvaxia vaccine in the Philippines, as the World Health Organization (WHO) Vaccine Safety Summit detailed in 2019. Independent scientists assessing results in Israel and the United Kingdom question the success of mass vaccination. As coronaviruses are constantly mutating, the effectiveness of these novel vaccines against new variants is doubtful.

2. PCR Tests Are Unreliable Public Health Measures.

While PCR tests may be able to diagnose a sick person in a short time window, they have almost no relevance for those who show no symptoms of illness. Positive PCR tests do not confirm illness or contagiousness and many result in ‘false positive cases’.

A recent review in the medical journal The Lancet estimated that isolation of false positive cases is “a net loss to the health, social and economic wellbeing of communities” and concluded that “PCR testing is therefore not the appropriate gold standard for evaluating a SARS-CoV-2 public health test.”

In January 2021, the WHO released new guidance on PCR tests, also warning of the danger of false positive results: “as disease prevalence decreases, the risk of false positive increases.”

Member states should stop testing healthy people and use those resources for treatment.

3. The Green Pass is legally disproportionate.

The proposed regulations infringe fundamental human rights, including rights to travel, assembly, privacy, conscience and free and informed consent. Recent scientific studies cast serious doubt on the effectiveness of draconian measures to limit disease spread, including travel restrictions and lockdown measures.

Implementing the Green Pass will require massive resources without a well-founded expectation of success. Investment in hospitals and protections for those at risk would be more effective and economical. At the very least, a cost–benefit analysis and debate are absolutely necessary.

4. The European Parliament Must Apply the Precautionary Principle.

COVID-19 vaccines have received only conditional approval; clinical trials will not be complete for months or years. Demanding that European Union citizens and visitors be subject to experimental medical products to exercise fundamental rights violates the precautionary principle enshrined in Article 191 of the Treaty of Functioning of the European Union.

How these vaccines will affect people in coming months or years is unknown. The risk of Antibody Dependent Enhancement (ADE) is real, i.e. that vaccinated individuals exposed to new viral strains may be at increased risk compared to those who have not been vaccinated. This potentially lethal risk is well-known to vaccine experts and is one of the main reasons why vaccine manufacturers refuse to accept liability for future injuries and deaths.

Several COVID-19 vaccines are based on a novel gene technology never used in healthy individuals before. Manufacturers sidelined the risks in modifying the human genome and triggering autoimmune diseases in the headlong rush to release the vaccines. On July 15, 2020, the European Parliament voted to waive the risk assessment for these vaccines under the Genetically Modified Organism (GMO) Regulation. Prominent scientists and doctors recently addressed these concerns in an open letter to the EMA. Further study on the impact of these gene therapies is required before making them compulsory.

5. Vaccine Manufacturers Fail to Warrant Effectiveness or Safety.

Esteemed Belgium lawyers recently concluded that the European Commission granted invalid liability and warranty exemptions to COVID-19 vaccine manufacturers. Given the lack of evidence of safety or effectiveness, manufacturers unsurprisingly refuse to guarantee either. Member States, and ultimately the electorate, will bear the burden of compensating and caring for victims of vaccine injury.

6. Inadequate Guarantee of Data Privacy.

Although the proposed regulation states that Member States will protect medical data, there is little to guarantee this protection. These medical data may be used to discriminate against individuals in violation of fundamental rights and freedoms.

7. Risk of Type Replacement and Viral Mutation.

Mass vaccination with imperfect vaccines – and none of the available vaccines is perfect – may lead to type replacement and viral mutation. It may well be vaccinated individuals, not unvaccinated ones, that pose the greatest risk of new, more virulent types of coronavirus infection. The classic example of this kind of type replacement occurred with widespread use of the pertussis vaccine, which led to new viral mutations that the existing vaccine did not block. In other words, it is unclear that mass vaccination will lead to an end to the coronavirus crisis.

8. Risk that Green Passes Become Permanent Without Due Consideration.

While the Parliament considers the Green Pass regulation as a temporary measure, it is unlikely to be so. Such restrictions usually become permanent, making the need for robust debate the more important. Could more vaccines be required under the Green Pass at a later date? Why should the Director-General of the World Health Organization have the power to make decisions about them? The long-term implications of the Green Pass require deliberation.

9. The European Parliament Must Uphold Democratic Values.

Too often since the beginning of the coronavirus pandemic, numbers have ruled instead of the rule of law. Small coteries of experts interpreting numbers have set policy instead of democratic legislatures and civil society. Numbers and studies are too often tailored to serve those who produce them. Europe cannot thrive if it relies on mathematical models to the exclusion of human models. The Parliament is entrusted to uphold democratic values.

***

Please take these points above into consideration and require open debate and analysis before you take further action on the Green Pass.

The citizens of Europe and the world are watching you — our liberty and security are in your hands. Do not let us down! Do not put the future of the European Union in jeopardy by desecrating one of its most fundamental principles: free movement within the Schengen Area.

Yours sincerely,

Robert F. Kennedy, Jr.
Chair, Children’s Health Defense

Senta Depuydt
President, Children’s Health Defense Europe

----------------------------------

**your signature**

405 signatures

Share this with your friends:

   

 

Latest Signatures
405 Judit Labundy Jul 23, 2021
404 Anna Birgersdotter Jul 21, 2021
403 Monica Kristiansson Jul 18, 2021
402 Gunilla Peterson Jul 18, 2021
401 Maria Wille Jul 18, 2021
400 Gunilla Djärf Jul 18, 2021
399 Margit Björk Jul 17, 2021
398 Micaela Lundgren Jul 17, 2021
397 Ewa Nordstrom Jul 07, 2021
396 Anders Gustafsson Jul 06, 2021
395 Brian O'Driscoll Jun 30, 2021
394 Maria Sikrooth Jun 22, 2021
393 Gabriela Q. Perez Jun 19, 2021
392 Anette Sarkany Jun 18, 2021
391 Alice Norgren Jun 18, 2021
390 Sazza Malmberg Jun 10, 2021
389 Marianne Viita Jun 10, 2021
388 Manuela Kielburger Jun 08, 2021
387 Gull-May Johansson Jun 07, 2021
386 Thomas Johanson Jun 07, 2021
385 Michel berhane Jun 06, 2021
384 Henrik Thurén Jun 05, 2021
383 Birgit Viktorsson Jun 03, 2021
382 Eva-Lisa Myntti May 28, 2021
381 Michael Svensson May 21, 2021
380 Monika Persson May 17, 2021
379 Martin Tiveskog May 15, 2021
378 Per Schunnesson May 15, 2021
377 Ewa Olsson May 15, 2021
376 Susanne Karlsson May 14, 2021
375 Christina Carlberg May 06, 2021
374 Christina Forsslund May 03, 2021
373 Else-Marie Wadén Werner May 03, 2021
372 Gunilla Gramell May 03, 2021
371 Robert Perrakoski May 03, 2021
370 Anna-Lena Lindström May 02, 2021
369 Ulf Strömberg Apr 30, 2021
368 Alexander Hansson Apr 29, 2021
367 Ulrika Tornare Apr 28, 2021
366 Marie Pettersson Apr 28, 2021
365 Kent Lindström Apr 27, 2021
364 Lasse Karagiannis Apr 24, 2021
363 Carola Fries Apr 23, 2021
362 Alexandra Matthews Apr 23, 2021
361 Maria Robertson Apr 22, 2021
360 Annika Andersson Apr 22, 2021
359 Pierre Fröde Apr 22, 2021
358 Tina Fröde Apr 22, 2021
357 Magnus Nordström Apr 22, 2021
356 Andreas Roth Apr 22, 2021
355 Rikard Lehmann Apr 22, 2021
354 Maria Waxin Lehmann Apr 21, 2021
353 Helena Jansson Apr 21, 2021
352 Eva M Larsson Apr 21, 2021
351 Charlotta Norlin Apr 20, 2021
350 Nicklas Lindahl Apr 20, 2021
349 Susanne Waller Apr 20, 2021
348 Birgitta Norlin Apr 19, 2021
347 Kent-Roger Bengtsson Apr 19, 2021
346 Irina Abraham Nasberg Apr 19, 2021
345 Bo Bogheim Apr 19, 2021
344 Marit Kenne Apr 19, 2021
343 Lena Zvenson Apr 19, 2021
342 Agneta Norlin Apr 19, 2021
341 Sylvia Lundin Apr 19, 2021
340 Johan Kaldén Apr 19, 2021
339 Jessica Wigertz Apr 19, 2021
338 Josefin Danielsson Apr 19, 2021
337 Barbara Larsson Apr 18, 2021
336 Inger Liljeholm Apr 18, 2021
335 Yemna Bohlman Apr 18, 2021
334 Maria Scharff Apr 18, 2021
333 Hanne Svensson Apr 18, 2021
332 Gun Karlsson Apr 18, 2021
331 Katarina Franzén Apr 17, 2021
330 Michael Andersson Apr 17, 2021
329 Jon Dahl Apr 16, 2021
328 Linda Karlström Apr 16, 2021
327 Marika Sörman Apr 16, 2021
326 Tony Dahlgren Apr 15, 2021
325 John Lepic Apr 14, 2021
324 Tobias Norlin Apr 14, 2021
323 Rita Carlsson Apr 14, 2021
322 Annika Nyholm Apr 13, 2021
321 Marianne Hunziker Apr 13, 2021
320 Marianne Ivarsson Apr 12, 2021
319 Annette Velin Bengtsson Apr 12, 2021
318 Antun Baldun Apr 12, 2021
317 Eva Lindström Apr 11, 2021
316 leif bengtsson Apr 11, 2021
315 Marcus Anon Apr 11, 2021
314 Thomas Svensson Apr 11, 2021
313 Pia Johansson Apr 11, 2021
312 Helena Ågren Apr 11, 2021
311 Ewa Granqvist Apr 11, 2021
310 Lena Finnström Apr 10, 2021
309 Inga Pålsson Apr 10, 2021
308 Kajsa Johansson Apr 10, 2021
307 Eva Eriksson Apr 10, 2021
306 Anneli Johansson Apr 10, 2021
305 Diamantis Koukouvinos Apr 09, 2021
304 Diana Almedal Apr 09, 2021
303 Clas Kling Apr 09, 2021
302 Mats Hogfeldt Apr 09, 2021
301 Mike Niva Apr 09, 2021
300 Carina Coombes Apr 09, 2021
299 Ruth Wallstedt Apr 09, 2021
298 Karin Vikström Apr 09, 2021

 


Stöd oss!

Donera via kort eller paypal


(går via naturalimmunity.org)

Donera i kryptovaluta


bitcoin: 1H3udR8EzwoMnAbNekEdagfSkvBVTqJyKM
bitcoin cash:qzxmfwl0ygwn0tayt43atdvzxrvwzn3ylq0vffprwm
ethereum: 0x88b5Bf87Eba1Cb9c8d71842A13dB9da77C5d5581

 

Mottagare:
pascal.canfin@europarl.europa.eu, bas.eickhout@europarl.europa.eu, cesar.luena@europarl.europa.eu, dan-stefan.motreanu@europarl.europa.eu, anja.hazekamp@europarl.europa.eu, nikos.androulakis@europarl.europa.eu, bartosz.arlukowicz@europarl.europa.eu, margrete.auken@europarl.europa.eu, simona.baldassarre@europarl.europa.eu, marekpawel.balt@europarl.europa.eu, traian.basescu@europarl.europa.eu, aurelia.beigneux@europarl.europa.eu, monika.benova@europarl.europa.eu, sergio.berlato@europarl.europa.eu, alexander.bernhuber@europarl.europa.eu, malin.bjork@europarl.europa.eu, simona.bonafe@europarl.europa.eu, delara.burkhardt@europarl.europa.eu, sara.cerdas@europarl.europa.eu, mohammed.chahim@europarl.europa.eu, tudor.ciuhodaru@europarl.europa.eu, nathalie.colin-oesterle@europarl.europa.eu, christian.doleschal@europarl.europa.eu, marco.dreosto@europarl.europa.eu, cyrus.engerer@europarl.europa.eu, eleonora.evi@europarl.europa.eu, agnes.evren@europarl.europa.eu, pietro.fiocchi@europarl.europa.eu, andreas.glueck@europarl.europa.eu, catherine.griset@europarl.europa.eu, jytte.guteland@europarl.europa.eu, teuvo.hakkarainen@europarl.europa.eu, martin.hojsik@europarl.europa.eu, par.holmgren@europarl.europa.eu, jan.huitema@europarl.europa.eu, yannick.jadot@europarl.europa.eu, adam.jarubas@europarl.europa.eu, petros.kokkalis@europarl.europa.eu, athanasios.konstantinou@europarl.europa.eu, ewa.kopacz@europarl.europa.eu, joannamaria.kopcinska@europarl.europa.eu, esther.delange@europarl.europa.eu, ryszardantoni.legutko@europarl.europa.eu, peter.liese@europarl.europa.eu, sylvia.limmer@europarl.europa.eu, javi.lopez@europarl.europa.eu, fulvio.martusciello@europarl.europa.eu, liudas.mazylis@europarl.europa.eu, joelle.melin@europarl.europa.eu, tilly.metz@europarl.europa.eu, silvia.modig@europarl.europa.eu, d.montserrat@europarl.europa.eu, alessandra.moretti@europarl.europa.eu, ville.niinisto@europarl.europa.eu, Ljudmila.novak@europarl.europa.eu, grace.osullivan@europarl.europa.eu, jutta.paulus@europarl.europa.eu, stanislav.polcak@europarl.europa.eu, jessica.polfjard@europarl.europa.eu, luisa.regimenti@europarl.europa.eu, frederique.ries@europarl.europa.eu, soraya.rodriguezramos@europarl.europa.eu, sandor.ronai@europarl.europa.eu, rob.rooken@europarl.europa.eu, silvia.sardone@europarl.europa.eu, christine.schneider@europarl.europa.eu, guenther.sidl@europarl.europa.eu, ivanvilibor.sincic@europarl.europa.eu, nicolae.stefanuta@europarl.europa.eu, linea.sogaard-lidell@europarl.europa.eu, nils.torvalds@europarl.europa.eu, veronique.trillet-lenoir@europarl.europa.eu, petar.vitanov@europarl.europa.eu, alexandr.vondra@europarl.europa.eu, mick.wallace@europarl.europa.eu, pernille.weiss@europarl.europa.eu, emma.wiesner@europarl.europa.eu, michal.wiezik@europarl.europa.eu, tiemo.woelken@europarl.europa.eu, anna.zalewska@europarl.europa.eu, eric.andrieu@europarl.europa.eu, maria.arena@europarl.europa.eu, hildegard.bentele@europarl.europa.eu, stefan.berger@europarl.europa.eu, michael.bloss@europarl.europa.eu, manuel.bompard@europarl.europa.eu, biljana.borzan@europarl.europa.eu, annika.bruna@europarl.europa.eu, cristiansilviu.busoi@europarl.europa.eu, carlo.calenda@europarl.europa.eu, catherine.chabaud@europarl.europa.eu, asger.christensen@europarl.europa.eu, deirdre.clune@europarl.europa.eu, antoni.cominioliveres@europarl.europa.eu, gianantonio.dare@europarl.europa.eu, ivan.david@europarl.europa.eu, margarita.delapisacarrion@europarl.europa.eu, estrella.dura@europarl.europa.eu, joao.ferreira@europarl.europa.eu, cindy.franssen@europarl.europa.eu, claudia.gamon@europarl.europa.eu, sven.giegold@europarl.europa.eu, jens.gieseke@europarl.europa.eu, suncana.glavak@europarl.europa.eu, nicolas.casares@europarl.europa.eu, marcel.degraaff@europarl.europa.eu, christophe.hansen@europarl.europa.eu, martin.haeusling@europarl.europa.eu, laura.huhtasaari@europarl.europa.eu, sophie.intveld@europarl.europa.eu, romana.jerkovic@europarl.europa.eu, irena.joveva@europarl.europa.eu, radan.kanev@europarl.europa.eu, karin.karlsbro@europarl.europa.eu, billy.kelleher@europarl.europa.eu, ondrej.knotek@europarl.europa.eu, katerina.konecna@europarl.europa.eu, constanze.krehl@europarl.europa.eu, danilooscar.lancini@europarl.europa.eu, norbert.lins@europarl.europa.eu, marian-jean.marinescu@europarl.europa.eu, sara.matthieu@europarl.europa.eu, dace.melbarde@europarl.europa.eu, nuno.melo@europarl.europa.eu, roberta.metsola@europarl.europa.eu, marlene.mortler@europarl.europa.eu, ulrike.mueller@europarl.europa.eu, demetris.papadakis@europarl.europa.eu, aldo.patriciello@europarl.europa.eu, piernicola.pedicini@europarl.europa.eu, lidia.pereira@europarl.europa.eu, sirpa.pietikainen@europarl.europa.eu, manuel.pizarro@europarl.europa.eu, rovana.plumb@europarl.europa.eu, manuela.ripa@europarl.europa.eu, michele.rivasi@europarl.europa.eu, daniela.rondinelli@europarl.europa.eu, marcos.ros@europarl.europa.eu, christel.schaldemose@europarl.europa.eu, andrey.slabakov@europarl.europa.eu, susana.solisperez@europarl.europa.eu, maria.spyraki@europarl.europa.eu, annalisa.tardino@europarl.europa.eu, hermann.tertsch@europarl.europa.eu, roza.thun@europarl.europa.eu, grzegorz.tobiszowski@europarl.europa.eu, marie.toussaint@europarl.europa.eu, istvan.ujhelyi@europarl.europa.eu, inese.vaidere@europarl.europa.eu, idoia.villanueva@europarl.europa.eu, nikolaj.villumsen@europarl.europa.eu, lucia.vuolo@europarl.europa.eu, sarah.wiener@europarl.europa.eu, jadwiga.wisniewska@europarl.europa.eu, chrysoula.zacharopoulou@europarl.europa.eu, bernd.lange@europarl.europa.eu, jan.zahradil@europarl.europa.eu, iuliu.winkler@europarl.europa.eu, anna-misel.asimakopoulou@europarl.europa.eu, marie-pierre.vedrenne@europarl.europa.eu, barry.andrews@europarl.europa.eu, tiziana.beghin@europarl.europa.eu, geert.bourgeois@europarl.europa.eu, saskia.bricmont@europarl.europa.eu, udo.bullmann@europarl.europa.eu, jordi.canas@europarl.europa.eu, daniel.caspary@europarl.europa.eu, miroslav.ciz@europarl.europa.eu, arnaud.danjean@europarl.europa.eu, paolo.decastro@europarl.europa.eu, raphael.glucksmann@europarl.europa.eu, marketa.gregorova@europarl.europa.eu, roman.haider@europarl.europa.eu, christophe.hansen@europarl.europa.eu, heidi.hautala@europarl.europa.eu, danuta.huebner@europarl.europa.eu, herve.juvin@europarl.europa.eu, karin.karlsbro@europarl.europa.eu, maximilian.krah@europarl.europa.eu, danilooscar.lancini@europarl.europa.eu, margarida.marques@europarl.europa.eu, gabriel.mato@europarl.europa.eu, sara.matthieu@europarl.europa.eu, emmanuel.maurel@europarl.europa.eu, maxette.pirbakas@europarl.europa.eu, carles.puigdemonticasamajo@europarl.europa.eu, samira.rafaela@europarl.europa.eu, inma.rodriguezpinero@europarl.europa.eu, massimiliano.salini@europarl.europa.eu, helmut.scholz@europarl.europa.eu, liesje.schreinemacher@europarl.europa.eu, sven.simon@europarl.europa.eu, dominik.tarczynski@europarl.europa.eu, mihai.tudose@europarl.europa.eu, kathleen.vanbrempt@europarl.europa.eu, mazaly.aguilar@europarl.europa.eu, nikos.androulakis@europarl.europa.eu, marek.belka@europarl.europa.eu, sergio.berlato@europarl.europa.eu, markus.buchheit@europarl.europa.eu, reinhard.buetikofer@europarl.europa.eu, marco.campomenosi@europarl.europa.eu, anna.cavazzini@europarl.europa.eu, dita.charanzova@europarl.europa.eu, clare.daly@europarl.europa.eu, nicola.danti@europarl.europa.eu, jeremy.decerle@europarl.europa.eu, lukeming.flanagan@europarl.europa.eu, jose.margallo@europarl.europa.eu, dino.giarrusso@europarl.europa.eu, marton.gyongyosi@europarl.europa.eu, svenja.hahn@europarl.europa.eu, yannick.jadot@europarl.europa.eu, agnes.jongerius@europarl.europa.eu, sandra.kalniete@europarl.europa.eu, sean.kelly@europarl.europa.eu, peter.kofod@europarl.europa.eu, andrey.kovatchev@europarl.europa.eu, miapetra.kumpula-natri@europarl.europa.eu, jean-lin.lacapelle@europarl.europa.eu, morten.lokkegaard@europarl.europa.eu, elzbieta.lukacijewska@europarl.europa.eu, david.mcallister@europarl.europa.eu, costas.mavrides@europarl.europa.eu, liudas.mazylis@europarl.europa.eu, javier.morenosanchez@europarl.europa.eu, gheorghe-vlad.nistor@europarl.europa.eu, urmas.paet@europarl.europa.eu, luisa.regimenti@europarl.europa.eu, manuela.ripa@europarl.europa.eu, annie.schreijer-pierik@europarl.europa.eu, joachim.schuster@europarl.europa.eu, pedro.silvapereira@europarl.europa.eu, massimiliano.smeriglio@europarl.europa.eu, witoldjan.waszczykowski@europarl.europa.eu, angelika.winzig@europarl.europa.eu, juanignacio.zoidoalvarez@europarl.europa.eu, cristiansilviu.busoi@europarl.europa.eu, zdzislaw.krasnodebski-office@europarl.europa.eu, mortenhelveg.petersen@europarl.europa.eu, patrizia.toia@europarl.europa.eu, lina.galvezmunoz@europarl.europa.eu, francois.alfonsi@europarl.europa.eu, nicola.beer@europarl.europa.eu, francois-xavier.bellamy@europarl.europa.eu, hildegard.bentele@europarl.europa.eu, tom.berendsen@europarl.europa.eu, vasile.blaga@europarl.europa.eu, michael.bloss@europarl.europa.eu, manuel.bompard@europarl.europa.eu, paolo.borchia@europarl.europa.eu, marc.botenga@europarl.europa.eu, markus.buchheit@europarl.europa.eu, martin.buschmann@europarl.europa.eu, jerzy.buzek@europarl.europa.eu, carlo.calenda@europarl.europa.eu, andrea.caroppo@europarl.europa.eu, maria.carvalho@europarl.europa.eu, pilar.delcastillo@europarl.europa.eu, ignazio.corrao@europarl.europa.eu, ciaran.cuffe@europarl.europa.eu, josianne.cutajar@europarl.europa.eu, nicola.danti@europarl.europa.eu, martina.dlabajova@europarl.europa.eu, christian.ehler@europarl.europa.eu, Valter.Flego@europarl.europa.eu, niels.fuglsang@europarl.europa.eu, claudia.gamon@europarl.europa.eu, jens.geier@europarl.europa.eu, nicolas.casares@europarl.europa.eu, bart.groothuis@europarl.europa.eu, christophe.grudler@europarl.europa.eu, henrike.hahn@europarl.europa.eu, robert.hajsel@europarl.europa.eu, ivo.hristov@europarl.europa.eu, ivars.ijabs@europarl.europa.eu, romana.jerkovic@europarl.europa.eu, eva.kaili@europarl.europa.eu, sean.kelly@europarl.europa.eu, izabela.kloc@europarl.europa.eu, lukasz.kohut@europarl.europa.eu, andrius.kubilius@europarl.europa.eu, miapetra.kumpula-natri@europarl.europa.eu, thierry.mariani@europarl.europa.eu, marisa.matias@europarl.europa.eu, eva.maydell@europarl.europa.eu, georg.mayer@europarl.europa.eu, joelle.melin@europarl.europa.eu, iskra.mihaylova@europarl.europa.eu, dan.nica@europarl.europa.eu, angelika.niebler@europarl.europa.eu, ville.niinisto@europarl.europa.eu, aldo.patriciello@europarl.europa.eu, mauri.pekkarinen@europarl.europa.eu, mikulas.peksa@europarl.europa.eu, tsvetelina.penkova@europarl.europa.eu, markus.pieper@europarl.europa.eu, clara.ponsatiobiols@europarl.europa.eu, sira.rego@europarl.europa.eu, manuela.ripa@europarl.europa.eu, jerome.riviere@europarl.europa.eu, rob.roos@europarl.europa.eu, sara.skyttedal@europarl.europa.eu, maria.spyraki@europarl.europa.eu, jessica.stegrud@europarl.europa.eu, beata.szydlo@europarl.europa.eu, riho.terras@europarl.europa.eu, grzegorz.tobiszowski@europarl.europa.eu, evzen.tosenovsky@europarl.europa.eu, marie.toussaint@europarl.europa.eu, isabella.tovaglieri@europarl.europa.eu, henna.virkkunen@europarl.europa.eu, pernille.weiss@europarl.europa.eu, carlos.zorrinho@europarl.europa.eu, matteo.adinolfi@europarl.europa.eu, andris.ameriks@europarl.europa.eu, rasmus.andresen@europarl.europa.eu, andrus.ansip@europarl.europa.eu, pascal.arimont@europarl.europa.eu, marekpawel.balt@europarl.europa.eu, erik.bergkvist@europarl.europa.eu, izaskun.bilbaobarandica@europarl.europa.eu, damian.boeselager@europarl.europa.eu, ioan-rares.bogdan@europarl.europa.eu, simona.bonafe@europarl.europa.eu, damien.careme@europarl.europa.eu, mohammed.chahim@europarl.europa.eu, angelo.ciocca@europarl.europa.eu, katalin.cseh@europarl.europa.eu, jakop.dalunde@europarl.europa.eu, margarita.delapisacarrion@europarl.europa.eu, salvatore.demeo@europarl.europa.eu, marco.dreosto@europarl.europa.eu, cyrus.engerer@europarl.europa.eu, cornelia.ernst@europarl.europa.eu, ismail.ertug@europarl.europa.eu, eleonora.evi@europarl.europa.eu, gheorghe.falca@europarl.europa.eu, pietro.fiocchi@europarl.europa.eu, gianna.gancia@europarl.europa.eu, giorgos.georgiou@europarl.europa.eu, helmut.geuking@europarl.europa.eu, jens.gieseke@europarl.europa.eu, klemen.groselj@europarl.europa.eu, valerie.hayer@europarl.europa.eu, martin.hojsik@europarl.europa.eu, alicia.homs@europarl.europa.eu, adam.jarubas@europarl.europa.eu , marina.kaljurand@europarl.europa.eu, othmar.karas@europarl.europa.eu, elena.kountoura@europarl.europa.eu, elzbieta.kruk@europarl.europa.eu, ioannis.lagos@europarl.europa.eu, bernd.lange@europarl.europa.eu, maria.marques@europarl.europa.eu, janusz.lewandowski@europarl.europa.eu, sylvia.limmer@europarl.europa.eu, elena.lizzi@europarl.europa.eu, adriana.maldonado@europarl.europa.eu, marian-jean.marinescu@europarl.europa.eu, dace.melbarde@europarl.europa.eu, csaba.molnar@europarl.europa.eu, ludek.niedermayer@europarl.europa.eu, jutta.paulus@europarl.europa.eu, sandra.pereira@europarl.europa.eu, dragos.pislaru@europarl.europa.eu, dennis.radtke@europarl.europa.eu, guido.reil@europarl.europa.eu, dominique.riquet@europarl.europa.eu, rob.rooken@europarl.europa.eu, bronis.rope@europarl.europa.eu, massimiliano.salini@europarl.europa.eu, jacek.saryusz-wolski@europarl.europa.eu, sven.schulze@europarl.europa.eu, guenther.sidl@europarl.europa.eu, ivanvilibor.sincic@europarl.europa.eu, jordi.sole@europarl.europa.eu, susana.solisperez@europarl.europa.eu, ivan.stefanec@europarl.europa.eu, antonio.tajani@europarl.europa.eu, roza.thun@europarl.europa.eu, tomas.tobe@europarl.europa.eu, nils.torvalds@europarl.europa.eu, mihai.tudose@europarl.europa.eu, viola.voncramon@europarl.europa.eu, emma.wiesner@europarl.europa.eu, angelika.winzig@europarl.europa.eu, isabel.wiseler@europarl.europa.eu, juanfernando.lopezaguilar@europarl.europa.eu, maite.pagaza@europarl.europa.eu, pietro.bartolo@europarl.europa.eu, emil.radev@europarl.europa.eu, magdalena.adamowicz@europarl.europa.eu, malik.azmani@europarl.europa.eu, katarina.barley@europarl.europa.eu, pernando.barrena@europarl.europa.eu, nicolas.bay@europarl.europa.eu, vladimir.bilcik@europarl.europa.eu, vasile.blaga@europarl.europa.eu, ioan-rares.bogdan@europarl.europa.eu, patrick.breyer@europarl.europa.eu, saskia.bricmont@europarl.europa.eu, joachim.brudzinski@europarl.europa.eu, jorge.buxadevillalba@europarl.europa.eu, damien.careme@europarl.europa.eu, caterina.chinnici@europarl.europa.eu, clare.daly@europarl.europa.eu, anna.donath@europarl.europa.eu, lena.duepont@europarl.europa.eu, cornelia.ernst@europarl.europa.eu, laura.ferrara@europarl.europa.eu, nicolaus.fest@europarl.europa.eu, iratxe.garcia-perez@europarl.europa.eu, jean-paul.garraud@europarl.europa.eu, marcel.degraaff@europarl.europa.eu, maria.grapini@europarl.europa.eu, sylvie.guillaume@europarl.europa.eu, andrzej.halicki@europarl.europa.eu, evin.incir@europarl.europa.eu, sophie.intveld@europarl.europa.eu, patryktomasz.jaki@europarl.europa.eu, marina.kaljurand@europarl.europa.eu, assita.kanko@europarl.europa.eu, fabienne.keller@europarl.europa.eu, peter.kofod@europarl.europa.eu, lukasz.kohut@europarl.europa.eu, moritz.koerner@europarl.europa.eu, alice.kuhnke@europarl.europa.eu, jeroen.lenaers@europarl.europa.eu, lukas.mandl@europarl.europa.eu, nuno.melo@europarl.europa.eu, roberta.metsola@europarl.europa.eu, nadine.morano@europarl.europa.eu, javier.morenosanchez@europarl.europa.eu, nicola.procaccini@europarl.europa.eu, paulo.rangel@europarl.europa.eu, terry.reintke@europarl.europa.eu, diana.ribaiginer@europarl.europa.eu, ralf.seekatz@europarl.europq.eu, michal.simecka@europarl.europa.eu, birgit.sippel@europarl.europa.eu, martin.sonneborn@europarl.europa.eu, tineke.strik@europarl.europa.eu, ramona.strugariu@europarl.europa.eu, annalisa.tardino@europarl.europa.eu, tomas.tobe@europarl.europa.eu, ioan-dragos.tudorache@europarl.europa.eu, milan.uhrik@europarl.europa.eu, tom.vandendriessche@europarl.europa.eu, bettina.vollath@europarl.europa.eu, jadwiga.wisniewska@europarl.europa.eu, elena.yoncheva@europarl.europa.eu, javier.zarzalejos@europarl.europa.eu, abir.alsahlani@europarl.europa.eu, bartosz.arlukowicz@europarl.europa.eu, larspatrick.berg@europarl.europa.eu, mara.bizzotto@europarl.europa.eu, malin.bjork@europarl.europa.eu, damian.boeselager@europarl.europa.eu, delara.burkhardt@europarl.europa.eu, olivier.chastel@europarl.europa.eu, tudor.ciuhodaru@europarl.europa.eu, nathalie.colin-oesterle@europarl.europa.eu, klara.dobrev@europarl.europa.eu, lucia.durisnicholsonova@europarl.europa.eu, cyrus.engerer@europarl.europa.eu, tanja.fajon@europarl.europa.eu, loucas.fourlas@europarl.europa.eu, romeo.franz@europarl.europa.eu, soren.gade@europarl.europa.eu, raphael.glucksmann@europarl.europa.eu, monika.hohlmeier@europarl.europa.eu, laura.huhtasaari@europarl.europa.eu, rasa.jukneviciene@europarl.europa.eu, beata.kempa@europarl.europa.eu, mislav.kolakusic@europarl.europa.eu, dietmar.koester@europarl.europa.eu, ondrej.kovarik@europarl.europa.eu, sergey.lagodinsky@europarl.europa.eu, Nathalie.Loiseau@europarl.europa.eu, leopoldo.lopez@europarl.europa.eu, jaak.madison@europarl.europa.eu, erik.marquardt@europarl.europa.eu, fulvio.martusciello@europarl.europa.eu, jan-christoph.oetjen@europarl.europa.eu, philippe.olivier@europarl.europa.eu, konstantinos.papadakis@europarl.europa.eu, anne-sophie.pelletier@europarl.europa.eu, mortenhelveg.petersen@europarl.europa.eu, sabrina.pignedoli@europarl.europa.eu, kati.piri@europarl.europa.eu, giuliano.pisapia@europarl.europa.eu, sira.rego@europarl.europa.eu, karlo.ressler@europarl.europa.eu, franco.roberti@europarl.europa.eu, rob.rooken@europarl.europa.eu, Domenec.RuizDevesa@europarl.europa.eu, isabel.santos@europarl.europa.eu, silvia.sardone@europarl.europa.eu, sylwia.spurek@europarl.europa.eu, paul.tang@europarl.europa.eu, cristian.terhes@europarl.europa.eu, romana.tomc@europarl.europa.eu, yana.toom@europarl.europa.eu, miguel.urbancrespo@europarl.europa.eu, tom.vandenkendelaere@europarl.europa.eu, hilde.vautmans@europarl.europa.eu, harald.vilimsky@europarl.europa.eu, lorant.vincze@europarl.europa.eu, petar.vitanov@europarl.europa.eu, alexandr.vondra@europarl.europa.eu, axel.voss@europarl.europa.eu, elissavet.vozemberg@europarl.europa.eu, maria.walsh@europarl.europa.eu, charlie.weimers@europarl.europa.eu, isabel.wiseler@europarl.europa.eu, tatjana.zdanoka@europarl.europa.eu, tomas.zdechovsky@europarl.europa.eu, juanignacio.zoidoalvarez@europarl.europa.eu, karima.delli@europarl.europa.eu, istvan.ujhelyi@europarl.europa.eu, sven.schulze@europarl.europa.eu, andris.ameriks@europarl.europa.eu, jan-christoph.oetjen@europarl.europa.eu, magdalena.adamowicz@europarl.europa.eu, joseramon.bauzadiaz@europarl.europa.eu, izaskun.bilbaobarandica@europarl.europa.eu, marco.campomenosi@europarl.europa.eu, massimo.casanova@europarl.europa.eu, ciaran.cuffe@europarl.europa.eu, jakop.dalunde@europarl.europa.eu, johan.danielsson@europarl.europa.eu, anna.deparnay-grunenberg@europarl.europa.eu, ismail.ertug@europarl.europa.eu, gheorghe.falca@europarl.europa.eu, giuseppe.ferrandino@europarl.europa.eu, joao.ferreira@europarl.europa.eu, mario.furore@europarl.europa.eu, soren.gade@europarl.europa.eu, isabel.garciamunoz@europarl.europa.eu, jens.gieseke@europarl.europa.eu, elsi.katainen@europarl.europa.eu, katerina.konecna@europarl.europa.eu, elena.kountoura@europarl.europa.eu, julie.lechanteux@europarl.europa.eu, boguslaw.liberadzki@europarl.europa.eu, elzbieta.lukacijewska@europarl.europa.eu, peter.lundgren@europarl.europa.eu, benoit.lutgen@europarl.europa.eu, marian-jean.marinescu@europarl.europa.eu, tilly.metz@europarl.europa.eu, giuseppe.milazzo@europarl.europa.eu, claudia.monteirodeaguiar@europarl.europa.eu, caroline.nagtegaal@europarl.europa.eu, philippe.olivier@europarl.europa.eu, rovana.plumb@europarl.europa.eu, tomasz.poreba@europarl.europa.eu, dominique.riquet@europarl.europa.eu, dorien.rookmaker@europarl.europa.eu, massimiliano.salini@europarl.europa.eu, vera.tax@europarl.europa.eu, barbara.thaler@europarl.europa.eu, petar.vitanov@europarl.europa.eu, elissavet.vozemberg@europarl.europa.eu, lucia.vuolo@europarl.europa.eu, roberts.zile@europarl.europa.eu, kosma.zlotowski@europarl.europa.eu, alviina.alametsa@europarl.europa.eu, pablo.ariasecheverria@europarl.europa.eu, petras.austrevicius@europarl.europa.eu, tom.berendsen@europarl.europa.eu, paolo.borchia@europarl.europa.eu, sara.cerdas@europarl.europa.eu, leila.chaibi@europarl.europa.eu, ignazio.corrao@europarl.europa.eu, josianne.cutajar@europarl.europa.eu, nicola.danti@europarl.europa.eu, angel.dzhambazki@europarl.europa.eu, markus.ferber@europarl.europa.eu, laura.ferrara@europarl.europa.eu, carlo.fidanza@europarl.europa.eu, Valter.Flego@europarl.europa.eu, tomasz.frankowski@europarl.europa.eu, daniel.freund@europarl.europa.eu, michael.gahler@europarl.europa.eu, vlad.gheorghe@europarl.europa.eu, maria.grapini@europarl.europa.eu, roman.haider@europarl.europa.eu, par.holmgren@europarl.europa.eu, brice.hortefeux@europarl.europa.eu, pierre.karleskind@europarl.europa.eu, ondrej.kovarik@europarl.europa.eu, maximilian.krah@europarl.europa.eu, ilhan.kyuchyuk@europarl.europa.eu, cesar.luena@europarl.europa.eu, colm.markey@europarl.europa.eu, georg.mayer@europarl.europa.eu, nora.mebarek@europarl.europa.eu, alessandra.moretti@europarl.europa.eu, ludek.niedermayer@europarl.europa.eu, Ljudmila.novak@europarl.europa.eu, andrey.novakov@europarl.europa.eu, jutta.paulus@europarl.europa.eu, anne-sophie.pelletier@europarl.europa.eu, markus.pieper@europarl.europa.eu, carles.puigdemonticasamajo@europarl.europa.eu, inma.rodriguezpinero@europarl.europa.eu, rob.roos@europarl.europa.eu, andre.rouge@europarl.europa.eu, patrizia.toia@europarl.europa.eu, kathleen.vanbrempt@europarl.europa.eu, johan.vanovertveldt@europarl.europa.eu, marianne.vind@europarl.europa.eu, henna.virkkunen@europarl.europa.eu, jorgen.warborn@europarl.europa.eu

One Reply to “Upprop: Vi kräver en debatt om EU:s gröna certifikat / Sveriges vaccinpass”

Comments are closed.